Cyclometalated Organometallic Emitter for OLED Efficiency and Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing light-emitting elements with phosphorescent materials face limitations in internal quantum efficiency and stability, particularly due to the statistical generation ratio of singlet and triplet excited states.
Innovation Solution
A novel light-emitting element is developed using a specific organometallic complex with a cyclometalated ligand structure, where the Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular Orbital (LUMO) are spatially separated, improving carrier injection and transport properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Use of energy by moving object
If phosphorescent materials are used to improve internal quantum efficiency, then light emission efficiency is improved, but device stability and lifetime are worsened
Solution Approach 1:
The patent changes the chemical composition parameters of the light-emitting material by using iridium complexes with specific cyclometalated ligands containing electron-withdrawing groups. This modifies the HOMO-LUMO energy levels and spatial distribution, achieving both high phosphorescence quantum yield (improved efficiency) and enhanced chemical stability (improved reliability) simultaneously.
Solution Approach 2:
The patent employs composite organometallic complex structures combining iridium center with specifically designed cyclometalated ligands featuring electron-withdrawing substituents. This composite material approach allows the synergistic combination of phosphorescence activity from the metal center and stability from the ligand framework, resolving the contradiction between efficiency and stability.
2Productivity
If conventional phosphorescent materials are used, then triplet excited state utilization is improved, but carrier balance and transport are worsened
Solution Approach 1:
The patent applies local quality modification by introducing electron-withdrawing groups at specific positions on the cyclometalated ligand framework. This creates localized electron-deficient regions that facilitate balanced carrier distribution, improving both triplet state utilization and carrier balance simultaneously through spatially differentiated electronic properties.
Solution Approach 2:
The patent modifies the electronic parameters of the light-emitting complex by adjusting the electron-withdrawing strength and position of ligand substituents. This changes the HOMO and LUMO energy levels and their spatial distribution, enabling optimized carrier injection, transport, and balance while maintaining high triplet excited state utilization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of this organometallic complex in the light-emitting element reduces drive voltage, enhances efficiency, and increases the stability and lifetime of the device by optimizing carrier balance and transport.
Implementation Method 1
When a voltage is applied to this light-emitting element, electrons and holes injected from the electrodes recombine to put the light-emitting substance into an excited state, and then light is emitted in returning from the excited state to the ground state.
Implementation Method 2
a compound capable of converting triplet excitation energy into light emission is called a phosphorescent compound (phosphorescent material). Light emission from a triplet excited state is referred to as phosphorescence.
Data Source
AI summary
A novel organometallic complex with high reliability is provided. A light-emitting element includes an EL layer between a pair of electrodes. The EL layer includes at least a light-emitting layer. The light-emitting layer contains an organometallic complex. The organometallic complex includes a first ligand and a second ligand which are coordinated to a central metal. The HOMO is distributed over the first ligand, and the LUMO is distributed over the second ligand. The first ligand and the second ligand are cyclometalated ligands.